Prepulse inhibition of acoustic startle, a measure of sensorimotor gating: effects of antipsychotics and other agents in rats

Pharmacology, Biochemistry, and Behavior
C JohanssonL Svensson

Abstract

Schizophrenic patients are deficient in various neurologic measures reflecting information processing. One such measure in prepulse inhibition (PPI) of acoustic startle, in which schizophrenics display less inhibition than normal subjects. PPI is also diminished in rats treated with psychotomimetic drugs such as amphetamine and phencyclidine. PPI has been suggested as a model relevant for studying the pathophysiology of schizophrenia. We studied the effect of a variety of antipsychotics and putative antipsychotics and some key reference compounds on the acoustic startle response (ASR) and PPI. Some, but not all, antipsychotics tested (mainly selective dopamine D2 antagonists) enhanced PPI. Remoxipride and clozapine, both of which are antipsychotics, and the very potent and highly selective D2 antagonist, NCQ-298, did not. It is concluded that enhanced PPI in otherwise untreated rats does not reflect antipsychotic efficacy. We further noted that the effect on PPI was independent of the effect on ASR.

References

Mar 1, 1992·Archives of General Psychiatry·D L BraffM A Geyer
Jan 1, 1992·Psychophysiology·R F Simons, B D Giardina
Sep 1, 1991·Pharmacology & Toxicology·G Tunnicliff
Jun 1, 1990·Journal of Medicinal Chemistry·S E HillverU Hacksell
Feb 1, 1990·Archives of General Psychiatry·D L Braff, M A Geyer
Jan 1, 1988·Psychopharmacology·R S MansbachD L Braff
Jun 1, 1994·Pharmacology, Biochemistry, and Behavior·D M JacksonA Bengtsson
Dec 1, 1993·The American Journal of Psychiatry·K S CadenheadD L Braff
Nov 1, 1993·Progress in Neuro-psychopharmacology & Biological Psychiatry·S B SchwarzkopfT Mitra
Jul 6, 1993·European Journal of Pharmacology·N MohellD M Jackson
Mar 1, 1993·Pharmacology, Biochemistry, and Behavior·N R Swerdlow, M A Geyer

❮ Previous
Next ❯

Citations

Nov 26, 2009·Psychopharmacology·Adam L Halberstadt, Mark A Geyer
Dec 17, 2010·Psychopharmacology·Sarah CorcoranErica Duncan
Nov 13, 2008·Cognitive Neurodynamics·Guy Sandner, Nathalie Monique Canal
Jun 16, 2004·Behavioural Brain Research·Kenichi MishimaMichihiro Fujiwara
Feb 24, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Shitij KapurMing Li
Oct 26, 2002·Biological Psychiatry·Bob OranjeRené S Kahn
Jun 14, 2002·Physiology & Behavior·Martha M Faraday
Feb 13, 2001·Pharmacology, Biochemistry, and Behavior·T BastI M White
Aug 18, 2001·Pharmacology, Biochemistry, and Behavior·K E StevensA C Collins
Mar 13, 2002·Pharmacology, Biochemistry, and Behavior·B PouzetJ Arnt
Oct 12, 2002·Pharmacology, Biochemistry, and Behavior·Cathy VaillancourtThérèse Di Paolo
Aug 1, 1997·Pharmacology, Biochemistry, and Behavior·Y Furuya, H Ogura
Apr 1, 1997·Pharmacology, Biochemistry, and Behavior·K M TrimbleD J King
May 11, 1999·Regulatory Peptides·K Uvnäs-MobergS Ahlenius
Apr 9, 1998·Progress in Neuro-psychopharmacology & Biological Psychiatry·P Curzon, M W Decker
Jul 20, 2002·Progress in Neurobiology·André Nieoullon
Aug 27, 1999·Progress in Neurobiology·M Koch
Oct 1, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Boris B QuednowFranz X Vollenweider
Oct 21, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Andrea GogosMaarten van den Buuse
Jun 2, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ming LiShitij Kapur
Feb 15, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Franz X VollenweiderBoris B Quednow
Nov 21, 2009·Molecular Brain·Oksana Kaidanovich-BeilinJames R Woodgett
Nov 2, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Anne H LeeWilliam N Frost
Mar 3, 2010·Annual Review of Clinical Psychology·Emma Barkus, Robin M Murray
May 6, 2003·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Elisabeth W P M DaenenJan M Van Ree
Feb 5, 2016·Pharmacological Reviews·David E Nichols
May 10, 2012·Behavioural Brain Research·Monica M BoltonJefferson W Kinney
Nov 17, 2009·Behavioural Brain Research·Sandra L McFaddenRussell E Morgan
Nov 20, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·Daisuke IshiiEiji Shimizu
Jan 30, 2004·Basic & Clinical Pharmacology & Toxicology·Daniel KlamerLennart Svensson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here